Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo.
about
Ursolic acid simultaneously targets multiple signaling pathways to suppress proliferation and induce apoptosis in colon cancer cellsFunctional promoter -765 G > C variant in COX-2 gene is associated with the susceptibility of breast cancer in Chinese Han women.Celecoxib decreases growth and angiogenesis and promotes apoptosis in a tumor cell line resistant to chemotherapyAssociation of the three common SNPs of cyclooxygenase-2 gene (rs20417, rs689466, and rs5275) with the susceptibility of breast cancer: an updated meta-analysis involving 34,590 subjects.Anticancer activity and chemoprevention of xenobiotic organosulfurs in preclinical model systemsAntiproliferative and apoptotic effects of β-elemene on human hepatoma HepG2 cellsSynthesis, docking and biological activities of novel hybrids celecoxib and anthraquinone analogs as potent cytotoxic agents.COX-2 dependent regulation of mechanotransduction in human breast cancer cellsSynergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer.Celecoxib and fish oil: a combination strategy for decreased inflammatory mediators in early stages of experimental mammary cancer.Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response.Prostaglandin E2inhibits resveratrol-induced apoptosis through activation of survival signaling pathways in HCT-15 cell linesCelecoxib in breast cancer prevention and therapy
P2860
Q28533451-58758941-5CF9-41B7-8604-CA76AB6992C6Q33600759-6E4B204F-8E71-403B-94BB-C2DD49F03579Q33913432-F84E2C31-D1D5-4CA1-A6FA-26E884B8A8D9Q34119332-1B469E19-0981-4E23-8F80-5817692E90B9Q34463928-79B89BB2-CF7E-41BA-9DA9-A49E674108ECQ34621667-C3D28117-F58D-457E-80E0-1414EED29F36Q34834711-6D698EBB-72F5-489B-AA24-FB98B733D4C3Q36214324-B385BBEA-DF67-4EB2-BA60-A87DD5F73AB9Q36919383-7A768088-A13B-4634-8E47-DFE5D58BCE81Q37678539-4E9369C3-D264-45B3-A104-7F7593E3C198Q37709099-05E8D551-EB2B-4C34-8EF3-B94C33D87593Q50893711-E280FA28-8496-4A19-9DA9-C6540058ED5DQ53223630-442CB10C-30BB-4D75-9FB4-38D25D1C6DA3Q58134125-BA6185E4-4857-4164-8C57-F1C526817B5FQ59135502-CC1CED13-D5BC-4CAE-B166-A8DF2B16EC79
P2860
Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Antitumor activity of the sele ...... t cancer in Vitro and in Vivo.
@ast
Antitumor activity of the sele ...... t cancer in Vitro and in Vivo.
@en
type
label
Antitumor activity of the sele ...... t cancer in Vitro and in Vivo.
@ast
Antitumor activity of the sele ...... t cancer in Vitro and in Vivo.
@en
prefLabel
Antitumor activity of the sele ...... t cancer in Vitro and in Vivo.
@ast
Antitumor activity of the sele ...... t cancer in Vitro and in Vivo.
@en
P2093
P2860
P356
P1476
Antitumor activity of the sele ...... t cancer in Vitro and in Vivo.
@en
P2093
Hai-Tao Guan
Hua-Feng Kang
Wang-Feng Lu
Wei-Li Min
Xi-Jing Wang
Xiao-Bin Ma
Zhi-Jun Dai
P2860
P2888
P356
10.1186/1475-2867-12-53
P577
2012-12-19T00:00:00Z
P5875
P6179
1031446941